Andreas Pabst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andreas Pabst has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Annette Wunsch
Department of Oral and Maxillofacial Surgery, University medical centre of the Johannes Gutenberg University Mainz, Augustusplatz 2, 55131 Mainz, Germany
1 shared publication - Christina Merkel
Department of Oral and Maxillofacial Surgery, University medical centre of the Johannes Gutenberg University Mainz, Augustusplatz 2, 55131 Mainz, Germany
1 shared publication - Felix Peter Koch
Oral and Maxillofacial Surgery, University medical centre of the Johannes Gutenberg University Mainz, Mainz, Germany
1 shared publication - Marco Blessmann
Division of Plastic, Reconstructive and Aesthetic Surgery, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany
1 shared publication - Ralf Smeets
University Hospital Aachen, Department of Oral and Maxillofacial Surgery, Aachen, Germany
1 shared publication - Sareh Said Yekta
Department of Orthodontics, RWTH Aachen University, Aachen, Germany
1 shared publication
Latest Publications
- Open Access
- 7 February 2011
- Published by Springer Nature in Head & Face Medicine
- Vol. 7 (1) , 4
The influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro
Background: Bisphosphonates are therapeutics of bone diseases, such as Paget's disease, multiple myeloma or osteoclastic metastases. As a severe side effect the bisphosphonate induced osteonecrosis of the jaw (BONJ) often requires surgical treatment and is accompanied with a disturbed wound healing. Therefore, the influence on adhesion and migration of human osteoblasts (hOB) after bisphosphonate therapy has been investigated by morphologic as well as gene expression methods. Methods: By a scratch wound experiment, which measures the reduction of defined cell layer gap, the morphology and migration ability of hOB was evaluated. A test group of hOB, which was stimulated by zoledronate 5 × 10-5M, and a control group of unstimulated hOB were applied. Furthermore the gene expression of integrin aVb3 and tenascin C was quantified by Real-Time rtPCR at 5data points over an experimental period of 14 days. The bisphosphonates zoledronate, ibandronate and clodronate have been compared with an unstimulated hOB control. Results: After initially identical migration and adhesion characteristics, zoledronate inhibited hOB migration after 50 h of stimulation. The integrinavb3 and tenascin C gene expression was effected by bisphosphonates in a cell line dependent manner with decreased, respectively inconsistent gene expression levels over time. The non-nitrogen containing bisphosphonates clodronate led to decreased gene expression levels. Conclusion: Bisphosphonates seem to inhibit hOB adhesion and migration. The integrin aVb3 and tenascin C gene expression seem to be dependent on the cell line. BONJ could be enhanced by an inhibition of osteoblast adhesion and migration. The gene expression results, however, suggest a cell line dependent effect of bisphosphonates, which could explain the interindividual differences of BONJ incidences.
- 7 February 2011
- Published by Springer Nature in Head & Face Medicine
- Vol. 7 (1) , 4
Open AccessThe influence of bisphosphonates on human osteoblast migration and integrin aVb3/tenascin C gene expression in vitro
Background: Bisphosphonates are therapeutics of bone diseases, such as Paget's disease, multiple myeloma or osteoclastic metastases. As a severe side effect the bisphosphonate induced osteonecrosis of the jaw (BONJ) often requires surgical treatment and is accompanied with a disturbed wound healing. Therefore, the influence on adhesion and migration of human osteoblasts (hOB) after bisphosphonate therapy has been investigated by morphologic as well as gene expression methods. Methods: By a scratch wound experiment, which measures the reduction of defined cell layer gap, the morphology and migration ability of hOB was evaluated. A test group of hOB, which was stimulated by zoledronate 5 × 10-5M, and a control group of unstimulated hOB were applied. Furthermore the gene expression of integrin aVb3 and tenascin C was quantified by Real-Time rtPCR at 5data points over an experimental period of 14 days. The bisphosphonates zoledronate, ibandronate and clodronate have been compared with an unstimulated hOB control. Results: After initially identical migration and adhesion characteristics, zoledronate inhibited hOB migration after 50 h of stimulation. The integrinavb3 and tenascin C gene expression was effected by bisphosphonates in a cell line dependent manner with decreased, respectively inconsistent gene expression levels over time. The non-nitrogen containing bisphosphonates clodronate led to decreased gene expression levels. Conclusion: Bisphosphonates seem to inhibit hOB adhesion and migration. The integrin aVb3 and tenascin C gene expression seem to be dependent on the cell line. BONJ could be enhanced by an inhibition of osteoblast adhesion and migration. The gene expression results, however, suggest a cell line dependent effect of bisphosphonates, which could explain the interindividual differences of BONJ incidences.